New hope for lymphoma patients: observational study tests Glofitamab's Real-World impact
NCT ID NCT07200375
Summary
This study aims to see how well and how safely a treatment called glofitamab works for Chinese adults whose aggressive lymphoma has come back or hasn't responded to their first treatment. It will follow 300 patients who are already planning to receive this therapy as part of their standard care. The main goal is to measure how long patients live without their cancer getting worse in a real-world setting.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chinese Academy of Medical Sciences Hematology Hospital;Lymphoma Diagnosis and Treatment Center
RECRUITINGTianjin, Tianjin Municipality, 301636, China
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, 510080, China
-
Harbin Medical University Cancer Hospital
RECRUITINGHarbin, 150081, China
-
Henan Cancer Hospital
RECRUITINGZhengzhou, 450008, China
-
Peking University Third Hospital
RECRUITINGBeijing, 100191, China
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
RECRUITINGShanghai, 200025, China
-
Shandong Cancer Hospital
RECRUITINGJinan, 250117, China
-
The First Affiliated Hospital of Wenzhou Medical University
RECRUITINGWenzhou, 325035, China
-
The First Bethune Hospital of Jilin University
RECRUITINGChangchun, China
-
Tianjin Cancer Hospital
RECRUITINGTianjin, 300060, China
-
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
RECRUITINGWuhan, 430030, China
-
Xiehe Hospital, Tongji Medical College Huazhong University of Science & Technology
RECRUITINGWuhan, 430022, China
Conditions
Explore the condition pages connected to this study.